/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Tenax Therapeutics Inc Share Price Today: Live Updates & Key Insights

Tenax Therapeutics Inc share price today is $14.35, up -4.09%. The stock opened at $15 against the previous close of $14.91, with an intraday high of $15.24 and low of $14.15.

Tenax Therapeutics Inc Share Price Chart

style
pb-0

Tenax Therapeutics Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Tenax Therapeutics Inc Share Price Performance

$14.35 -0.0409(-4.09%) TENX at 23 Mar 2026 03:28 PM Biotechnology
Lowest Today 14.15
Highest Today 15.24
Today’s Open 15
Prev. Close 14.91
52 Week High 18.38
52 Week Low 4.63
Day’s Range: Low 14.15 High 15.24
52-Week Range: Low 4.63 High 18.38
1 day return -
1 Week return +1.5
1 month return +18.12
3 month return +14.78
6 month return +117.27
1 year return +129.19
3 year return -69.99
5 year return -99.57
10 year return -

Tenax Therapeutics Inc Institutional Holdings

T. Rowe Price Health Sciences 16.96

Ikarian Capital, LLC 10.39

Fidelity Advisor Biotechnology I 5.17

Siren, L.L.C. 4.59

TD Health Sciences - I 4.33

RTW INVESTMENTS, LLC 4.06

BOOTHBAY FUND MANAGEMENT, LLC 3.78

Bvf Inc 3.65

Millennium Management LLC 3.25

Marshall Wace Asset Management Ltd 3.20

Vanguard Total Stock Mkt Idx Inv 3.11

Vanguard Group Inc 2.74

Vivo Capital, LLC 2.24

Sphera Funds Management Ltd. 2.04

Morgan Stanley - Brokerage Accounts 1.91

Integral Health Asset Management, LLC 1.79

HHG PLC 1.79

Woodline Partners LP 1.54

FMR Inc 1.51

Citadel Advisors Llc 1.39

Renaissance Technologies Corp 1.35

Vanguard Institutional Extnd Mkt Idx Tr 1.12

Adage Capital Partners Gp LLC 0.89

Velan Capital Investment Management LP 0.89

T. Rowe Price Health Sciences Port 0.86

Bridgeway Ultra-Small Company 0.72

Persistent Asset Partners Limited 0.70

Fidelity Extended Market Index 0.46

Blackrock Extended Mkt Fund CF 0.26

Extended Equity Market Fund K 0.23

Fidelity Series Total Market Index 0.16

Dimensional US Small Cap ETF 0.16

Fidelity Total Market Index 0.14

DFA US Small Cap I 0.09

Spartan Extended Market Index Pool F 0.09

Vanguard Balanced Index Inv 0.08

NT Ext Equity Mkt Idx Fd - NL 0.07

Spartan Total Market Index Pool G 0.07

Vanguard Instl Ttl Stck Mkt Idx Tr 0.07

Northern Trust Extended Eq Market Idx 0.06

Tenax Therapeutics Inc Market Status

Strong Buy: 3

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Tenax Therapeutics Inc Fundamentals

Market Cap 245.93 M

PB Ratio 2.5175

PE Ratio 0.0

Enterprise Value 235.27 M

Total Assets 104.23 M

Volume 227874

Tenax Therapeutics Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-7033875 -7.0M, FY22:-11043147 -11.0M, FY21:-32730139 -32.7M, FY20:-9871184 -9.9M, FY19:-8394363 -8.4M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:-1000 -0.0M

Quarterly Net worth Q3/2025:-15804000 -15.8M, Q2/2025:-10847000 -10.8M, Q1/2025:-10408000 -10.4M, Q3/2024:-3960469 -4.0M, Q2/2024:-3575673 -3.6M

About Tenax Therapeutics Inc & investment objective

Company Information Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Chapel Hill, North Carolina.

Organisation Biotechnology

Employees 14

Industry Biotechnology

CEO Mr. Christopher T. Giordano

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Tenax Therapeutics Inc FAQs

What is the share price of Tenax Therapeutics Inc today?

The current share price of Tenax Therapeutics Inc is $14.35.

Can I buy Tenax Therapeutics Inc shares in India?

Yes, Indian investors can buy Tenax Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Tenax Therapeutics Inc shares in India?

You can easily invest in Tenax Therapeutics Inc shares from India by:

Can I buy fractional shares of Tenax Therapeutics Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Tenax Therapeutics Inc?

Tenax Therapeutics Inc has a market cap of $245.93 M.

In which sector does Tenax Therapeutics Inc belong?

Tenax Therapeutics Inc operates in the Biotechnology sector.

What documents are required to invest in Tenax Therapeutics Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Tenax Therapeutics Inc?

The PE ratio of Tenax Therapeutics Inc is N/A and the PB ratio is 2.52.